NEW YORK (CBSNewYork) — A new study is providing reassuring news for breast cancer patients undergoing chemotherapy during the pandemic.

A new NYU Langone Health study found breast cancer patients treated with chemo did not have an increased risk for COVID infection compared to patients who had other therapies.

READ MORE: COVID-19: Experts Say Delta Variant Spreads Quickly And Is Dominant Strain In Under-Vaccinated Areas

The study followed more than 3,000 breast cancer patients treated at the height of the pandemic.

READ MORE: New York's COVID State Of Emergency Set To Expire Thursday

“We also found that patients who contracted COVID-19 who had previously received chemotherapy did not have a higher mortality rate,” said Dr. Douglas Marks, a medical oncologist with NYU Langone Health’s Perlmutter Cancer Center.

Older and overweight patients, however, were found to have a higher risk of dying from COVID.

MORE NEWS: Every NYC Resident Now Eligible For In-Home COVID Vaccine, De Blasio Says

Researchers say this study is believed to be the first to look at whether breast cancer therapies can affect COVID-19 infection and death risk.

CBSNewYork Team